fakta.uk
Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Jason Karlawish, who writes STAT’s Neurotransmissions column. Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, or wherever you get your podcasts. Get alerts about each new episode by signing up for the “First Opinion Podcast” newsletter. […]
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them. You can submit a […]
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also the author of the Health Care Inc. newsletter. You can reach Bob on Signal at bobjherman.09. The federal government has sent a record $16 […]
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — European policymakers on Thursday unveiled a compromise framework for the biggest shakeup to E.U. pharmaceutical policy in two decades, as they try to strike a balance between expanding faster access to drugs across the […]
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. Last call: If you haven’t yet, fill out your 2025 health AI bingo card (and/or 2026 predictions) by tonight! Read the rest… medical Pendidikan Pendidikan […]
ASH 2025 had both rain and sun, positive and negative data in Orlando, Fla.ASH 2025 was in Orlando, Fla. Adam Feuerstein / STAT Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The […]
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here. Apparently, some vets are already using GLP-1s for diabetic cats. We are all a clinical trial or two away from “Ozempets” becoming mainstream. But do we really want our pets to shun the treats we give them? Tips and pet […]
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54. ORLANDO, Fla. — With sales […]
The Advisory Committee on Immunization Practices’ (ACIP) meetings used to be a geek’s dream: hours of long, maybe dreary presentation of extensive data followed by lengthy discussions that drilled into details of vaccine safety, effectiveness, and the best way to balance protecting people and risks and costs. Not health secretary Robert F. Kennedy Jr.’s ACIP. […]
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can reach Katie on Signal at palmer.01. In the massive demonstration arena of Chicago’s McCormick Place conference complex this week, hundreds of computer monitors lit up […]
